Indefinite Delivery Contract HHSO100201700017I

Award Date 3/9/17
Last Date to Order 3/8/23
Ultimate Awardee
Not listed
Pricing Type
Cost Plus Fixed Fee
Legislative Mandate
Clinger Cohen Act
National Interest Action
None
Award Type
Multiple
Primary Consortia Member
Not listed
Similar IDVs
The federal contract IDV award is for an Indefinite Delivery Contract with a ceiling value of $146,300,000 awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency under the Department of Health and Human Services. The contract is focused on providing pre-clinical models of infectious diseases to support research, development, and evaluation of medical countermeasures such as therapeutics, vaccines, and diagnostics. The contract has a single award to...
The federal contract IDV award, with an ID of 75N93024D00022, was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency under the Department of Health and Human Services (HHS). This single-award Indefinite Delivery Contract, potentially valued up to $146,300,000, is for pre-clinical models of infectious diseases under task areas A, B, and C. The prime contractor, Texas Biomedical Research Institute, will provide a range of services including developing...
The federal contract IDV award described is for an Indefinite Delivery Contract (IDC) valued at up to $1,115,573.34, awarded by the Cybersecurity and Infrastructure Security Agency (CISA), a civilian federal agency, to the prime contractor Southern Research Institute. The contract has a period of performance from March 29, 2005 to November 30, 2006. Under this IDC, Southern Research Institute provides a range of contract research services, including drug discovery and development, emerging...
This Indefinite Delivery Contract (IDC) was awarded by the Office of the Assistant Secretary for Preparedness and Response (ASPR), a civilian federal agency, to Southern Research Institute, a non-profit research organization. The contract has a ceiling value of $5,000,000 and a performance period ending on July 13, 2012. The contract aims to procure "OTHER SPECIAL STUDIES AND ANALYSES" for ASPR. Two task orders have been issued under this IDC to date, valued at $244,710 and $240,723...
This indefinite delivery contract (IDC) was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the Department of Health and Human Services, to the American Foundation For Biological Research, doing business as the Biomedical Research Institute. The $146.3 million single-award IDC has a period of performance from July 15, 2024 to July 14, 2031. The purpose of this IDC is to provide NIAID with the capability and capacity to develop and employ...
The federal contract IDV award is a single-award Indefinite Delivery Contract issued by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Pharmacology Discovery Services Taiwan, LTD., a for-profit Taiwanese organization. The contract, valued up to $146.3M, supports NIAID's preclinical infectious disease research by providing a range of animal and animal replacement models for screening and evaluating candidate countermeasures such as therapeutics, vaccines,...
The Department of Health and Human Services' Office of the Assistant Secretary for Preparedness and Response awarded a single award indefinite delivery contract to Southern Research Institute located in Birmingham, Alabama. With a potential value of $100 million and a period of performance through September 2027, this contract aims to procure biological animal model and medical countermeasure development services in support of the Biomedical Advanced Research and Development Authority. A $4.68...
This indefinite delivery contract (IDC) was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services, to the IIT Research Institute (IITRI), a subsidiary of the Illinois Institute of Technology. The contract has a ceiling value of $146.3 million and a period of performance through July 2031. The purpose of this IDC is to provide NIAID with a range of preclinical research services related to the development and...
The National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services, awarded a single-award Indefinite Delivery Contract valued up to $146,300,000 to Southern Research Institute, a non-profit research organization, to develop and employ animal and animal replacement models of infectious diseases. The contract will support screening, product evaluation, and eventual clinical evaluation of vaccines, therapeutics, and...
This single-award Indefinite Delivery Contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency under the Department of Health and Human Services, to Battelle Memorial Institute, a non-profit organization and manufacturer of goods, to provide pre-clinical models of infectious diseases. The $146.3 million, 7-year contract has a completion date of July 14, 2031 and was awarded on July 15, 2024. The contract aims to develop and employ animal and...

The federal contract IDV award provides indefinite delivery of nonclinical biological services to the Department of Health and Human Services (HHS), specifically the Office of the Assistant Secretary for Preparedness and Response (ASPR). The purpose is to establish a network of Good Laboratory Practices (GLP) facilities capable of conducting animal testing and other analytical services to support the development of medical countermeasures against chemical, biological, radiological, and nuclear (CBRN) threats, pandemic influenza, and emerging infectious diseases.

The $45,050,000 multiple award IDIQ contract was awarded to Southern Research Institute, a non-profit research organization, in March 2017. It has a period of performance through March 2023. Task orders under this IDIQ will fund activities such as hit-to-lead compound progression studies, assay development and validation, animal model creation, and efficacy evaluations for emerging antiviral and antimicrobial medical countermeasures. The original solicitation did not use any set-asides and sought proposals from organizations with existing GLP capabilities, AAALAC accreditation, USDA animal research licenses, and select agent registration to provide these nonclinical services in support of HHS medical countermeasure development priorities.

Generated 8/22/24, 3:01 PM